Freenome, Inc. (FRNM) stock
FRNMNasdaqServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026
$10.41−0.20 (-1.89%)
Close on Nov 13, 2026Market cap $1.15BP/E –Yield –
Freenome ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
No ebitda figures for Freenome
Freenome has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?